Citations

Showing 10 of 108083 citations.

An omnibus test for differential distribution analysis of microbiome sequencing data
King, Emily A. , Deek, Rebecca A. , Wei, Zhi , Grill, Diane E. , Chen, Jun , Yu, Yue , Ballman, Karla V. , Wei, Zhi

Mayo Clinic

Bioinformatics | October 11, 2017 | Volume: 34 | Issue: 4 | Pages: 643-651

10.1093/bioinformatics/btx650 | PMID 29040451 Get It

AbstractMotivationOne objective of human microbiome studies is to identify differentially abundant microbes across biological conditions. Previous statistical methods focus on detecting the shift in the abundance and/or prevalence of the microbes and treat the dispersion (spread of the data) as a nuisance. These methods also assume that the dispersion is the same across conditions, an assumption which may not hold in presence of sample heterogeneity. Moreover, the widespread outliers in the microbiome sequencing data make existing parametric models not overly robust. Therefore, a robust and powerful method that allows covariate-dependent dispersion and addresses outliers is still needed for differential abundance analysis.ResultsWe introduce a novel test for differential distribution analysis of microbiome sequencing data by jointly testing the abundance, prevalence and dispersion. The test is built on a zero-inflated negative binomial regression model and winsorized count data to account for zero-inflation and outliers. Using simulated data and real microbiome sequencing datasets, we show that our test is robust across various biological conditions and overall more powerful than previous methods.Availability and implementationR package is available at https://github.com/jchen1981/MicrobiomeDDA.Supplementary informationSupplementary data are available at Bioinformatics online.
Surgical Approach Impacts Posterior Femoral Cutaneous Nerve Outcomes After Proximal Hamstring Repair
Wilson, Thomas J. , Spinner, Robert J. , Krych, Aaron J. , Krych, Aaron J

Mayo Clinic

Clinical Journal of Sport Medicine | October 11, 2017 | Volume: 29 | Issue: 4 | Pages: 281-284

10.1097/jsm.0000000000000514 | PMID 31241529 Get It

Objective: The goal of this study was to characterize the risk of intraoperative injury to the posterior femoral cutaneous nerve and to evaluate potential risk factors for injury during surgical repair of proximal hamstring injuries. Design: Retrospective cohort study. Setting: Single tertiary referral center. Patients: The cohort consisted of all patients presenting to a single institution with a proximal hamstring avulsion injury who were managed with surgical repair between January 1, 2000 and August 1, 2016. A total of 67 patients were included in the cohort. Independent Variables: Variables assessed for their association with postoperative numbness in the distribution of the posterior femoral cutaneous nerve included age, sex, body mass index, mechanism of injury, time to surgical repair, and incision used. Main Outcome Measures: The primary outcome of interest was neurologic symptoms referable to the posterior femoral cutaneous nerve. Results: Postoperatively, 13 patients (19%) developed new numbness in the distribution of the posterior femoral cutaneous nerve. One patient reported neuropathic pain and paresthesias associated with the numbness. The use of a gluteal crease incision was the only predictive factor for postoperative numbness in the posterior femoral cutaneous nerve distribution (odds ratio 8.67; 95% confidence interval, 2.30-42.80; P = 0.001). Conclusions: The current study provides data that can be used in discussing the risks and benefits of surgical repair with patients and when weighing the pros and cons of using a gluteal crease versus longitudinal incision.
Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation
Han, Sangbin , Lee, Sanghoon , Yang, Ju Dong , Leise, Michael D. , Ahn, Joonghyun , Kim, Seonwoo , Jung, Kangha , Gwak, Mi Sook , Kim, Gaab Soo , Ko, Justin Sangwook , Leise, Michael Douglas, Yang, Ju Dong

Mayo Clinic

Liver Transplantation | October 11, 2017 | Volume: 24 | Issue: 1 | Pages: 44-55

10.1002/lt.24961 | PMID 29024412 Get It

Platelets interact with tumor cells and promote metastasis. The importance of platelets in posttransplant hepatocellular carcinoma (HCC) recurrence is unclear. Thus, we aimed to evaluate the association between preoperative platelet count (PLT) and HCC recurrence after living donor liver transplantation. Of 359 recipients of livers from living donors for HCC, 209 of 240 patients who had preoperative PLT ≤75 × 109/L were matched with 97 of 119 patients who had preoperative PLT >75 × 109/L using propensity score matching, with an unfixed matching ratio based on factors such as tumor biology. The cutoff value of 75 × 109/L was set based on optimum stratification analysis. Survival analysis was performed with death as a competing risk event. The primary outcome was overall HCC recurrence. The median follow‐up time was 59 months. Before matching, recurrence probability at 1, 2, and 5 years after transplantation was 4.7%, 9.2%, and 11.3% for the low platelet group and 14.5%, 23.0%, and 30.5% for the high platelet group. Recurrence risk was significantly greater in the high platelet group in both univariate (hazard ratio [HR] = 3.09; 95% confidence interval [CI], 1.86‐5.14; P < 0.001) and multivariate analyses (HR = 2.10; 95% CI, 1.23‐3.60; P = 0.007). In the matched analysis, recurrence risk was also greater in the high platelet group in both univariate (HR = 2.33; 95% CI, 1.36‐4.01; P = 0.002) and multivariate analyses (HR = 1.90; 95% CI, 1.02‐3.54; P = 0.04). Preoperative PLT had no interaction with the Milan criteria, alpha‐fetoprotein level, Edmonson grade, microvascular invasion, or intrahepatic metastasis. Incorporation of preoperative PLT into the Milan criteria significantly improved predictive power. Inflammation‐based scores including neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio, and the inflammation‐based index did not show superiority to preoperative PLT in predicting HCC recurrence. In conclusion, preoperative PLT appears to be an important host factor affecting HCC recurrence after living donor liver transplantation. Liver Transplantation 24 44–55 2018 AASLD.
Minimal residual disease analysis in myeloma – when, why and where
Yanamandra, Uday , Kumar, Shaji

Mayo Clinic

Leukemia & Lymphoma | October 11, 2017 | Volume: 59 | Issue: 8 | Pages: 1772-1784

10.1080/10428194.2017.1386304 | PMID 29019452 Get It

Editorial: a novel approach to monitor mucosal healing in coeliac disease—as simple as shifting goalposts? Authors’ reply
Murray, Joseph A. , Murray, J A , Fang, Hong

Mayo Clinic

Alimentary Pharmacology & Therapeutics | October 11, 2017 | Volume: 46 | Issue: 9 | Pages: 895-896

10.1111/apt.14333 | PMID 29023882 Get It

This article is linked to Tye‐Din and Fang et al papers. To view these articles visit https://doi.org/10.1111/apt.14287 and https://doi.org/10.1111/apt.14250.
Therapy related‐chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML
Patnaik, Mrinal M. , Vallapureddy, Rangit, Yalniz, Fevzi , Hanson, Curtis A. , Ketterling, Rhett P. , Finke, Christy M. , Al‐Kali, Aref , Gangat, Naseema , Tefferi, Ayalew , Yalniz, Fevzi F, Lasho, Terra L. , Gangat, Naseema , Tefferi, Ayalew , Ketterling, Rhett P , Yalniz, Fevzi

Mayo Clinic

American Journal of Hematology | October 11, 2017 | Volume: 93 | Issue: 1 | Pages: 65-73

10.1002/ajh.24939 | PMID 29023992 Get It

AbstractTherapy related myeloid neoplasms (t‐MN) including therapy related myelodysplastic syndromes (t‐MDS) and acute myeloid leukemia (t‐AML) are associated with aggressive disease biologies and poor outcomes. In this large (n = 497) and informative (inclusive of molecular and cytogenetic information) chronic myelomonocytic leukemia (CMML) patient cohort, we demonstrate key biological insights and an independent prognostic impact for t‐CMML. T‐CMML was diagnosed in 9% of patients and occurred approximately 7 years after exposure to prior chemotherapy and/or radiation therapy. In comparison to de novo CMML, t‐CMML patients had higher LDH levels, higher frequency of karyotypic abnormalities and had higher risk cytogenetic stratification. There were no differences in the distribution of gene mutations and unlike t‐MDS/AML, balanced chromosomal translocations, abnormalities of chromosome 11q23 (1%) and Tp53 mutations (<2%) were uncommon. Molecularly integrated CMML prognostic models were not effective in risk stratifying t‐CMML patients and responses to hypomethylating agents were dismal with no complete responses. Median overall (OS) and leukemia free survival (LFS) was shorter for t‐CMML in comparison to d‐CMML (Median OS 10.9 vs 26 months and median LFS 50 vs 127 months) and t‐CMML independently and adversely impacted OS (P = .0001 HR 2.1 95% CI 1.4‐3.0). This prognostic impact was retained in the context of the Mayo Molecular Model (P = .001, HR 2.4, 95% CI 1.5‐3.7) and the GFM prognostic model (P < .0001, HR 2.15, 95% CI 1.5‐3.7). In summary, we highlight the unique genetics and independent prognostic impact of t‐CMML, warranting its inclusion as a separate entity in the classification schema for both CMML and t‐MN.
Gluten-free diet among school-age children in Olmsted County, Minnesota
Absah, Imad , Almallouhi, Eyad

Mayo Clinic

Avicenna Journal of Medicine | October 11, 2017 | Volume: 07 | Issue: 04 | Pages: 171-175

10.4103/ajm.ajm_42_17 | PMID 29119084 Get It

Abstract Objective: To assess the prevalence of gluten-free diet (GFD) among school-age children in Olmsted County, Minnesota, and compare it with the prevalence of celiac disease (CD) in the same age group. Methods: We performed a population-based study in Olmsted County using a survey to collect information from the six school districts in the county for the academic year 2014–2015. The survey contained questions to (1) assess the prevalence of GFD among school-age children in the public schools of Olmsted County; (2) assess the prevalence of CD among school-age children in Olmsted County; and (3) determine the indications for GFD in these children. We used the infrastructure of the Rochester Epidemiology Project (REP) to calculate the prevalence of CD in children aged 4–18 years in December 2014. Results: Using the REP data, we identified sixty patients with CD in the county aged 4–18 years; the prevalence of CD among school students in 2014 was 193.6/100,000. The prevalence of GFD in Olmsted County children, however, was higher, at 265/100,000 according to the survey from the school districts. The prevalence of GFD was highest in Rochester, the largest city. GFD was more common among children in secondary schools. Conclusion: According to our study, there are more children on GFD than the actual cases of CD in Olmsted County during the study period. This finding could be related to an increased number of children without CD who are following GFD for other indications.
Agminated segmental plaque‐type blue nevus associated with hypertrichosis and soft tissue hypertrophy: Report of a case and review of the literature
Hunjan, Manrup , Mohandas, Desiree, Bridges, Alina G. , Tollefson, Megha M. , Hunjan, Manrup K , Tollefson, Megha

Mayo Clinic

Pediatric Dermatology | October 11, 2017 | Volume: 35 | Issue: 1 | Pages: No page available

10.1111/pde.13303 | PMID 29023980 Get It

AbstractBlue nevi are common skin neoplasms that typically present as asymptomatic solitary papules, although they may rarely occur in an agminated configuration. We describe a case of agminated blue nevus in a segmental facial distribution associated with soft tissue hypertrophy and hypertrichosis in a 16‐year‐old boy and present a review of the literature. Although they are generally considered to be benign, concurrent soft tissue changes occurring within an agminated blue nevus should be investigated thoroughly to exclude alternate diagnoses.
Building sustainable social and solidarity economies: Place-based and network-based strategies of alternative development organizations in India
Kumbamu, Ashok

Mayo Clinic

Community Development | October 11, 2017 | Volume: 49 | Issue: 1 | Pages: 18-33

10.1080/15575330.2017.1384744 Get It

60 Utility of t wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
Sugrue, Alan , Killu, AM, DeSimone, CV, Chahal, C. Anwar A. , Vogt, J. J., Křemen, Václav , Hai, Jo Jo , Hodge, DO, Acker, NG, Geske, JB, Ackerman, M. J., Ommen, SR, Noseworthy, PA, Brady, PA, Geske, Jeffrey B. , Chahal, Choudhary Anwar A , Kremen, Vaclav , Geske, Jeffrey B , Killu, Ammar M. , Desimone, C, Lin, Gen‐Min , Brady, PA

Mayo Clinic

Moderated poster session 3 | October 11, 2017 | Volume: No volume available | Issue: No issue available | Pages: A35-A36

10.1136/heartjnl-2017-ics17.59 Get It